Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Surmodics, Inc. (SRDX)

37.82   0.59 (1.58%) 07-02 18:29
Open: 36.51 Pre. Close: 37.23
High: 37.98 Low: 36.9
Volume: 26,234 Market Cap: 529(M)
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 38.04 - 38.19 38.19 - 38.35
Low: 36.53 - 36.68 36.68 - 36.85
Close: 37.56 - 37.84 37.84 - 38.12

Technical analysis

as of: 2022-07-01 4:25:23 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 46.86     One year: 54.73
Support: Support1: 36.87    Support2: 34.86
Resistance: Resistance1: 40.11    Resistance2: 46.86
Pivot: 36.58
Moving Average: MA(5): 37.18     MA(20): 37.08
MA(100): 40.19     MA(250): 46.93
MACD: MACD(12,26): -0.3     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 66.6     %D(3): 53.3
RSI: RSI(14): 52.6
52-week: High: 62.27  Low: 32.43
Average Vol(K): 3-Month: 38 (K)  10-Days: 41 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SRDX ] has closed below upper band by 13.5%. Bollinger Bands are 38% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 25 Jun 2022
Surmodics, Inc. (NASDAQ:SRDX) Holdings Reduced by Diversified Trust Co - Defense World

Thu, 16 Jun 2022
Here's Why You Should Hold on to Surmodics (SRDX) Stock For Now - Nasdaq

Wed, 15 Jun 2022
Insiders at Surmodics, Inc. (NASDAQ:SRDX) must be relieved they sold stock as market valuation descends to US$498m - Simply Wall St

Thu, 09 Jun 2022
Haemonetics (HAE) Up 28.2% Since Last Earnings Report: Can It Continue? - Nasdaq

Wed, 01 Jun 2022
Surmodics to Present at Jefferies Healthcare Conference - Yahoo Finance

Fri, 29 Apr 2022
Surmodics (SRDX) Beats on Q2 Earnings, Revises FY22 View - Zacks Investment Research

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 14 (M)
Shares Float 11 (M)
% Held by Insiders 3 (%)
% Held by Institutions 91.7 (%)
Shares Short 308 (K)
Shares Short P.Month 365 (K)

Stock Financials

EPS 0.3
EPS Est Next Qtl 0.01
EPS Est This Year 0.31
EPS Est Next Year 0.23
Book Value (p.s.) 10.07
Profit Margin (%) -10.9
Operating Margin (%) -14.2
Return on Assets (ttm) -4.8
Return on Equity (ttm) -7.7
Qtrly Rev. Growth -25.4
Gross Profit (p.s.) 2.75
Sales Per Share 6.93
EBITDA (p.s.) -0.35
Qtrly Earnings Growth 0
Operating Cash Flow -8 (M)
Levered Free Cash Flow -7 (M)

Stock Valuations

PE Ratio 126.06
PEG Ratio -2.8
Price to Book value 3.75
Price to Sales 5.45
Price to Cash Flow -69.76

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.